その他、和解金の受取額、工具他2件
- 【期間】
| 年度 | その他 | 和解金の受取額 | 工具 | 会計方針の変更を反映した当期首残高 | 外部顧客への売上高 - 医療・医薬品事業 |
|---|
| 2009/03 | 0.29億 | | 552百万 | | 6.27億 | | - | | - | |
| 2010/03 | 0.51億 | +75.9% | - | | 5.15億 | -17.9% | - | | - | |
| 2011/03 | 1億 | +96.1% | - | | 4.05億 | -21.4% | - | | - | |
| 2012/03 | 0.97億 | -3% | - | | 3.74億 | -7.7% | - | | - | |
| 2013/03 | 1.98億 | +104.1% | - | | 3.93億 | +5.1% | - | | - | |
| 2014/03 | 0.71億 | -64.1% | - | | 6.56億 | +66.9% | 430億 | | - | |
| 2015/03 | 0.48億 | -32.4% | - | | 7.46億 | +13.7% | - | | - | |
| 2016/03 | 1.6億 | +233.3% | - | | 11.5億 | +54.7% | - | | - | |
| 2017/03 | 8.77億 | +448.1% | - | | 11.6億 | +0.1% | - | | - | |
| 2018/03 | 6.48億 | -26.1% | - | | 9.89億 | -14.4% | - | | 8.19億 | |
| 2019/03 | 13.5億 | +108.8% | - | | 9億 | -9% | - | | 76.6億 | +835.4% |
| 2020/03 | 13.4億 | -0.8% | - | | 12.7億 | +41.6% | - | | 182億 | +137.8% |
| 2021/03 | 18.9億 | +41.1% | - | | 13.3億 | +4.6% | - | | 246億 | +34.8% |
| 2022/03 | 13.4億 | -29.4% | - | | 19.1億 | +43.1% | - | | 235億 | -4.4% |
| 2023/03 | 26.7億 | +99.7% | - | | 19.1億 | +0.1% | - | | 254億 | +8.4% |
| 2024/03 | 26.5億 | -1% | - | | 23.8億 | +24.7% | - | | 293億 | +15% |
